Literature DB >> 3132917

Arachidonic acid can induce leukotriene C4 formation by purified human eosinophils in the absence of other stimuli.

P T Kok1, M L Hamelink, A M Kijne, J Verhagen, L Koenderman, P L Bruynzeel.   

Abstract

Stimulation of purified human eosinophils with 50 microM arachidonic acid leads to the production of leukotriene C4, 15-hydroxy-eicosatetraenoic acid and 15-series leukotrienes. The ratio of the amounts of leukotriene C4 and 15-lipoxygenase products was found to be strongly dependent on the arachidonic acid concentration, being relatively large at low arachidonic acid concentrations and very small at high arachidonic acid concentrations. In the presence of 1 microM platelet-activating factor a significant elevation of leukotriene C4 formation is observed, whereas the formation of 15-lipoxygenase products remains unaltered. As arachidonic acid was found to be capable of inducing a fast, transient rise in the cytosolic free Ca2+ concentration, this explains at least partly its ability to induce the Ca2+-dependent formation of leukotriene C4.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3132917     DOI: 10.1016/s0006-291x(88)81148-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Inhibition of platelet-activating factor- and zymosan-activated serum-induced chemotaxis of human neutrophils by nedocromil sodium, BN 52021 and sodium cromoglycate.

Authors:  P L Bruijnzeel; R A Warringa; P T Kok
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

2.  Inhibitory effects of nedocromil sodium on the in vitro induced migration and leukotriene formation of human granulocytes.

Authors:  P L Bruijnzeel; R A Warringa; P T Kok; M L Hamelink; J Kreukniet
Journal:  Drugs       Date:  1989       Impact factor: 9.546

3.  Involvement of protein tyrosine kinases in activation of human eosinophils by platelet-activating factor.

Authors:  G Dent; N M Munoz; X Zhu; E Rühlmann; H Magnussen; A R Leff; K F Rabe
Journal:  Immunology       Date:  2000-06       Impact factor: 7.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.